LEADER 00000cam  2200625Ia 4500 
001    880827447 
003    OCoLC 
005    20210108111445.6 
006    m     o  d         
007    cr cnu---unuuu 
008    140531s2014    enk     ob    001 0 eng d 
010    2013042467 
020    9780190200657 
020    0190200650 
020    9780199974580 
020    0199974586 
035    (OCoLC)880827447|z(OCoLC)882262721|z(OCoLC)883365562
       |z(OCoLC)1103259257|z(OCoLC)1228606090 
035    Ebook Central Perpetual Titles 
040    EBLCP|beng|epn|cEBLCP|dIDEBK|dN$T|dOCLCQ|dMOR|dYDX|dOCLCO
       |dMERUC|dOCLCO|dOCLCQ|dSAV|dOCLCO|dUAB|dOCLCA|dOCLCQ|dWYU
       |dOCLCO|dOCLCA|dAGLDB|dOCLCO|dOCL|dG3B|dIGB|dSTF|dAUW|dBTN
       |dINTCL|dMHW|dSNK|dVT2|dUSU|dE7B|dOCLCF|dYDXCP|dS4S|dS8I
       |dOCLCA|dOCLCQ|dOCLCA 
049    txum 
050  4 RM301.27 
072  7 MED|x071000|2bisacsh 
082 04 615.1901|223 
100 1  Tansey, Michael,|eauthor. 
245 10 Intelligent drug development :|btrials and errors in 
       clinical research /|cMichael Tansey. 
264  1 Oxford ;|aNew York :|bOxford University Press,|c[2014] 
300    1 online resource (241 pages) 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
504    Includes bibliographical references (pages 213-215) and 
       index. 
505 0  Aiming for excellence -- The target product profile and 
       its uses -- Planning the individual clinical trial -- 
       Distilling the essence of the protocol: the protocol 
       synopsis -- Redistillation: eliminating impurities by 
       carrying out protocol feasibility -- The optimal blend: 
       the approved synopsis and the final protocol -- Of 
       chickens and eggs: the sponsors' dilemma -- Clinician or 
       clinical trialist: the physicians' dilemma -- What about 
       the customer? the patients' dilemma -- About time: making 
       meetings matter -- The brain-scrambling, fit-inducing, 
       mind-numbing technicolor laser show. 
506    Available only to authorized UTEP users. 
520    Clinical research is heavily regulated and involves 
       coordination of numerous pharmaceutical-related 
       disciplines. Each individual trial involves contractual, 
       regulatory, and ethics approval at each site and in each 
       country. Clinical trials have become so complex and 
       government requirements so stringent that researchers 
       often approach trials too cautiously, convinced that the 
       process is bound to be insurmountably complicated and 
       riddled with roadblocks. A step back is needed, an 
       objective examination of the drug development process as a
       whole, and recommendations made for streamlining the 
       proces. 
588 0  Print version record. 
650  0 Clinical trials|xEthics. 
650  0 Clinical trials|xMethods. 
650  0 Drug approval|xMethods. 
650  0 Medical protocols. 
650 12 Drug Approval|xmethods. 
650 22 Clinical Protocols. 
650 22 Clinical Trials as Topic|xethics. 
650 22 Clinical Trials as Topic|xmethods. 
655  7 Methods (Music)|2fast|0(OCoLC)fst01423850 
776 08 |iPrint version:|aTansey, Michael.|tIntelligent Drug 
       Development.|dOxford : Oxford University Press, 2014
       |z9780199974580|w(DLC)  2013042467|w(OCoLC)861895187 
856 40 |uhttp://0-ebookcentral.proquest.com.lib.utep.edu/lib/utep
       /detail.action?docID=1696428|zTo access this resource 
LOCATION CALL # STATUS
 Internet  Electronic Book    AVAILABLE